Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US army trainees: Results of a retrospective nationwide seroprevalence survey

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1776-1778

  Ludwig, Sharon L ^b   Brundage, John F ^a   Kelley, Patrick W ^b   Nang, Roberto ^b   Towle, Cynthia ^b   Schnurr, David P ^b   Crawford Miksza, Leta ^b   Gaydos, Joel C ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ADENOVIRUS; ADENOVIRUS 7; ADULT; ANTIBODY DETECTION; ARMY; ARTICLE; DISEASE PREDISPOSITION; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROTYPE;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; MALE; MILITARY PERSONNEL; PREVALENCE; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 0031769029     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314498     Document Type: Article

References (15)

1. Dingle JH, Langmuir AD. Epidemiology of acute respiratory disease in military recruits. Am Rev Respir Dis 1968;97:1-65.
2. Hilleman MR, Werner JH. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 1954;85:183-8.
3. Dudding BA, Top FH, Winter PE, et al. Acute respiratory disease in military trainees: the Adenovirus Surveillance Program, 1966-1971. Am J Epidemiol 1973;97:187-98.
4. Chanock RM, Ludwig W, Huebner RJ, et al. Immunization by selective infection with type 4 adenovirus grown in human diploid cell culture. JAMA 1966;195:445-52.
5. Top FH, Grossman RA, Bartelloni PJ, et al. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis 1971;124:148-54.
6. Top FH, Buescher EI, Bancroft WH, Russell PK. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis 1971;124:155-60.
7. Dudding BA, Top FH, Scott RM, et al. An analysis of hospitalizations for acute respiratory disease. I. Recruits immunized with adenovirus type 4 and type 7 vaccines. Am J Epidemiol 1972;95:140-7.
8. Collis PB, Dudding BA, Winter PE, et al. Adenovirus vaccines in military recruit populations: a cost-benefit analysis. J Infect Dis 1973;128:745-50.
9. Top FH. Control of adenovirus acute respiratory disease in US Army trainees. Yale J Biol Med 1975;48:185-95.
10. Brundage JF, Gunzenhauser JD, Longfield JN, et al. Epidemiology and control of acute respiratory disease with emphasis on group A beta-hemolytic streptococcus: a decade of US Army experience. Pediatrics 1996;97(suppl):964-70.
11. Barazza EM. Adenovirus outbreak - Fort Jackson. Med Surveil Monthly Rep (US Army Center for Health Promotion and Preventive Medicine) 1995;1:9.
12. Gaydos CA, Gaydos JC. Adenovirus vaccines in the US military. Mil Med 1995;160:300-4.
13. Kelley, P. Susceptibility to measles and rubella among US Army recruits: a seroepidemiologic analysis of risk factors, temporal trends, and disease control policy options [dissertation]. Baltimore: Johns Hopkins University, 1994.
14. Crawford-Miksza LK, Schnurr DP. Quantitative colorimetric microneutralization assay for characterization of adenovirus. J Clin Microbiol 1994;32:2331-4.
15. Takafuji ET, Gaydos JC, Allen RG, Top FH. Simultaneous administration of live, enteric-coated adenovirus types 4, 7, and 21 vaccines: safety and immunogenicity. J Infect Dis 1979;140:48-53.